Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rea

Showing results (341-350 of 374) with videos related to

Pageof 38
Sort By:
The Journal of Experimental Medicine|September 6, 2001
Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cellsJ P Medema, D H Schuurhuis, D Rea, et al.
Circulation|April 19, 2006
Beta2-adrenergic receptor genetic variants and risk of sudden cardiac deathNona Sotoodehnia, David S Siscovick, Matteo Vatta, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 25, 2020
Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast CancerC Conefrey, J L Donovan, R C Stein, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2018
Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trialM G M Derks, E Bastiaannet, W van de Water, et al.
British Journal of Cancer|October 2, 2003
Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancerM S Braun, F Adab, C Bradley, et al.
Leukemia|April 29, 2016
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemiaJ L Steegmann, M Baccarani, M Breccia, et al.
Circulation|February 11, 2009
Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populationsW H Linda Kao, Dan E Arking, Wendy Post, et al.
Circulation|January 17, 2020
Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Shock-Refractory Cardiac ArrestMohamud R Daya, Brian G Leroux, Paul Dorian, et al.
Emergency Medicine Journal : EMJ|September 22, 2020
Occupational exposures and programmatic response to COVID-19 pandemic: an emergency medical services experienceDavid L Murphy, Leslie M Barnard, Christopher J Drucker, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 27, 2012
Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trialJ Bartlett, P Canney, A Campbell, et al.
Pageof 38

Showing results (341-350 of 374) with videos related to

Sort By:
Pageof 38
The Journal of Experimental Medicine|September 6, 2001
Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cellsJ P Medema, D H Schuurhuis, D Rea, et al.
Circulation|April 19, 2006
Beta2-adrenergic receptor genetic variants and risk of sudden cardiac deathNona Sotoodehnia, David S Siscovick, Matteo Vatta, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 25, 2020
Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast CancerC Conefrey, J L Donovan, R C Stein, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2018
Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trialM G M Derks, E Bastiaannet, W van de Water, et al.
British Journal of Cancer|October 2, 2003
Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancerM S Braun, F Adab, C Bradley, et al.
Leukemia|April 29, 2016
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemiaJ L Steegmann, M Baccarani, M Breccia, et al.
Circulation|February 11, 2009
Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populationsW H Linda Kao, Dan E Arking, Wendy Post, et al.
Circulation|January 17, 2020
Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Shock-Refractory Cardiac ArrestMohamud R Daya, Brian G Leroux, Paul Dorian, et al.
Emergency Medicine Journal : EMJ|September 22, 2020
Occupational exposures and programmatic response to COVID-19 pandemic: an emergency medical services experienceDavid L Murphy, Leslie M Barnard, Christopher J Drucker, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 27, 2012
Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trialJ Bartlett, P Canney, A Campbell, et al.
Pageof 38